Gematologiya i Transfuziologiya

Papers
(The TQCC of Gematologiya i Transfuziologiya is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Clinical recommendations for the diagnosis and treatment of aplastic anemia (2019 edition)9
Thermolability of factor VIII in donor fresh frozen blood plasma6
Cytogenetic and molecular genetic diagnostics in oncohematological disorders: a position paper of the Organization of Molecular Geneticists in Oncology and Oncohematology5
Outbreak of mass poisoning with anticoagulant rodenticides5
Mechanisms of action of immunomodulatory drugs — from teratogenicity to treatment of multiple myeloma4
Minimal residual disease and b-cell subpopulation monitoring in acute b-lymphoblastic leukaemia patients treated on rall-2016 protocol4
Detection of measurable residual disease in adults with acute leukaemia4
Risk-adapted combined therapy with arsenic trioxide and all-trans-retinoic acid for de novo acute promyelocytic leuкaemia3
Implementation of allogeneic hematopoietic stem cell transplantation from unrelated donors from Russian and foreign registries3
A prospective study of the monitoring of patients with chronic myeloid leukemia upon withdrawal of tyrosine kinase inhibitor therapy3
National clinical recommendations for the diagnosis and treatment of mastocytosis3
Clinical guidelines for the management of patients with paroxysmal nocturnal hemoglobinuria3
Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia3
Observation in a treatment-free remission in chronic myeloid leukemia patients with a stable deep molecular response in the Russian portion of the international multicenter population based study EUTO3
Comparison of the treatment results in adult patients with acute Ph-negative lymphoblastic leukemia on protocols of the Russian multicenter studies ALL-2009 and ALL-20163
Thrombotic thrombocytopenic purpura in pregnancy. Giving birth or not giving birth, that is the question3
Methodological aspects of the detection of minimal residual disease in patients with acute leukemia2
Diagnosis and choice of haemostatic therapy during surgery in patients with combined coagulation factor V and VIII defi ciency2
Immunoglobulin genes and stereotyped antigenic receptors in chronic lymphocytic leukemia and other lymphoproliferative diseases2
Treatment tactics for a patient with acquired hemophilia: continuous infusion of recombinant activated coagulation factor VII and the inhibitor eradication2
Coexistence of multiple myeloma and chronic myeloleukosis in one patient2
The role of D-dimer in stroke risk stratification in patients with atrial fibrillation2
Formation of a cohort of anticovid plasma donors with high-titer antibodies neutralizing SARS-CoV-22
Dermatologic adverse events of Bcr-Abl tyrosine kinase inhibitors2
Kinetic parameters of complement activation in patients with paroxysmal nocturnal hemoglobinuria during eculizumab therapy2
Myeloidderived peripheral blood suppressor cells at haematopoietic stem cell mobilisation in multiple myeloma patients2
Structure and signifi cance of cytogenetic abnormalities in patients with multiple myeloma2
Endothelial-platelet interaction in sepsis2
Next generation sequencing HLA-typing of recipients and donors of allogeneic haematopoietic stem cells2
Next-generation sequencing-based molecular genetic profiling in adults with acute myeloid leukaemia2
Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia1
Interim results of the PML-16, PML-19 protocols for primary mediastinal large B-cell lymphoma therapy1
μ-Heavy chain disease associated with systemic amyloidosis and non-amyloid deposits. Diffi culties in diagnosis and therapy1
Supplement intravenous iron therapy in cardiac surgery1
Anemia in primary hyperparathyroidism1
Contribution of social and demographic parameters to the long-term survival prognosis of chronic myeloid leukemia patients1
Management of immune thrombocytopenia during COVID-19 pandemic1
Clinical guidelines for cryosupernatant transfusions1
Minor histocompatibility antigens as targets for T-cell immunotherapy1
Whole-body magnetic resonance imaging for diagnosis and treatment monitoring in multiple myeloma1
Kaposi’s sarcoma in HIV-negative patient with primary myelofi brosis1
Chimeric antigen receptor T-cell therapy in adult patients with B-cell lymphoproliferative diseases1
Combined head injuries in hemophilia patients with signs of victim behaviour1
Optimal blood management as priority route in cardiac surgery1
Vaccination against COVID-19 for hematologic patients: A review of clinical guidelines1
Characteristics and trends in the work of the Blood Service of the Russian Federation in 2016–20201
Management of patients with hemophilia A on emicizumab prophylactic treatment: Recommendation from Russian Experts1
Impact of natural killer cell’s functional reconstruction on the results of allogeneic hematopoietic stem cell transplantation1
A comprehensive measures ensuring the safety of blood component transfusions1
Physiological and pathological role of factor XII1
Identifi cation of ABO, RH and KEL blood group antigens with serology and genotyping methods1
Molecular and genetic verification of von Willebrand disease type 2N1
First experience of allogeneic haematopoietic stem cell transplantation in patients with mantle cell lymphoma with a mutation in the <i>TP53</i> gene1
Cytokines in the mechanisms of regulation of monocytopoiesis in ischemic heart disease1
Regional hematology service registration system for the Russian Federation1
Dynamic laboratory control of iron deficiency correction in neurosurgical patients1
Conformational disorders of RBC membranes during long-term storage1
Successful treatment of relapses of primary mediastinal large B-cell lymphoma with central nervous system involvement1
Evaluation of the effi ciency of the activity of the register of potential donors of hematopoietic stem cells1
Blood groups and acute respiratory viral infection COVID-191
COVID-19 in patients with congenital bleeding disorders in Russia1
Immune thrombocytopenic purpura and thrombotic thrombocytopenic purpura — diagnostic difficulties and errors1
Advantages and disadvantages of femoral port systems in hematоlogical patients with superior vena cava syndrome1
Oligoclonality and subpopulation structure of bone marrow T-cells in patients with aplastic anaemia1
Hemophilia in the city of Novosibirsk and Novosibirsk region: Clinical phenotype, comorbidity1
Role of the intensive care in allogeneic hematopoietic stem cell transplantation1
Infectious complications and their contributing risk factors after allogeneic hematopoietic stem cell transplantation1
Significance of TPMT and NUDT15 variants in 6-mercaptopurine metabolism in acute lymphoblastic leukaemia/lymphoma patients1
A long-term follow-up of observation in treatment-free remission in patients with chronic myeloid leukemia1
Experience of haematological observatory ward during COVID-10 pandemic1
0.028090000152588